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Abstract
Background: Endoplasmic reticulum (ER) stress has pathophysiological relevance in vascular diseases and merges with
proteasome function. Proteasome inhibition induces cell stress and may have therapeutic implications. However, whether
proteasome inhibition potentiates ER stress-induced apoptosis and the possible mechanisms involved in this process are
unclear.
Methodology/Principal Findings: Here we show that proteasome inhibition with MG132, per se at non-lethal levels,
sensitized vascular smooth muscle cells to caspase-3 activation and cell death during ER stress induced by tunicamycin (Tn).
This effect was accompanied by suppression of both proadaptive (KDEL chaperones) and proapoptotic (CHOP/GADD153)
unfolded protein response markers, although, intriguingly, the splicing of XBP1 was markedly enhanced and sustained. In
parallel, proteasome inhibition completely prevented ER stress-induced increase in NADPH oxidase activity, as well as
increases in Nox4 isoform and protein disulfide isomerase mRNA expression. Increased Akt phosphorylation due to
proteasome inhibition partially offset the proapoptotic effect of Tn or MG132. Although proteasome inhibition enhanced
oxidative stress, reactive oxygen species scavenging had no net effect on sensitization to Tn or MG132-induced cell death.
Conclusion/Relevance: These data indicate unfolded protein response-independent pathways whereby proteasome
inhibition sensitizes vascular smooth muscle to ER stress-mediated cell death. This may be relevant to understand the
therapeutic potential of such compounds in vascular disease associated with increased neointimal hyperplasia.
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Introduction
Endoplasmic reticulum (ER) stress, an important pathophysiological
component of diseases such as cancer, diabetes mellitus, neurodegen-
eration and atherosclerosis, triggers complex specific cell signaling
known as the Unfolded Protein Response (UPR) [1–3]. The UPR is
primarily adaptive and aimed to restore ER homeostasis, but can, if
ER stress is intense/sustained or if adaptation fails, lead itself to
apoptosis via specific pathways such as those involving transcription
factor CHOP/GADD153 [2,3]. Oxidative stress strongly converges
with ER stress in a way that the UPR triggers early reactive oxygen
species (ROS) generation, which in turn contributes to sustain
proadaptive and/or proapoptotic UPR signaling [4,5]. Both ER-
resident oxidoreductases and mitochondria contribute to such ROS
generation [2,4,5], but a particular role for Nox4 NADPH oxidase
isoform has been reported in vascular smooth muscle cells (VSMC)
[5,6], and in endothelial cells [7]. Mechanisms whereby cell survival is
coupled to UPR signaling and ROS generation are yet unclear and
appear to be highly variable among distinct cell types [5].
The ubiquitin-proteasome system interfaces with and impor-
tantly regulates the UPR. This effect, however, is complex and
seemingly ambiguous in a number of aspects. Increased protea-
some-mediated degradation of un/misfolded proteins merges with
the UPR as an adaptive ER homeostatic mechanism [8,9], so that
proteasome inhibition may potentially lead to ER stress due to lack
of removal of damaged proteins [10]. In turn, proteasome
inhibitors promote myeloma cell death and disrupt UPR signaling
by preventing IRE1a-mediated splicing of the mRNA coding for
active transcription factor XBP1, one of the main UPR branches
[11]. Also, proteasome inhibition is known to promote oxidative
stress [12], but an opposite effect can occur in some cell types [13].
In addition, proteasome function is associated with either cell
survival [10,13,14] or death [8,12,15–17], depending on cell type
and specific pathophysiological circumstances such as prolifera-
tive status. Understanding such questions has become increa-
singly relevant, given that proteasome inhibition is rapidly
emerging as a therapeutic strategy, e.g., against several types of
tumors [11,12,15].
ER stress and UPR signaling have been shown to mediate
several aspects of the pathogenesis and natural history of
atherosclerosis and vascular inflammation [1–5]. In parallel, the
ubiquitin-proteasome system acts as mediator of vascular cell
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cytokine effects (reviewed in ref. 18). Therefore, vascular effects of
proteasome inhibitors have been investigated, with reported
evidence suggesting that such compounds have atheroprotective
effects and reduce neointima after injury [18–22]. However, there
is equally substantive information on worsening of atherosclerosis,
endothelial function and induction of a rupture-prone plaque
phenotype by proteasome inhibition [18,23,24]. While such
discrepancies appear dependent on model, species, stage of disease
and particularly on the degree of proteasome inhibition [25], these
controversies indicate that better knowledge of mechanisms
underlying effects of the proteasome, as well as proteasome
inhibitors, in vascular cells is important in order to provide
rational advances. Particularly, mechanisms of proteasome
inhibitor effects on vascular cell viability are unclear, specifically
those regarding their likely interplay with UPR signaling, oxidative
stress and NADPH oxidase.
In this study, we investigated, in VSMC exposed to the classical
ER stressor tunicamycin, the role of proteasome inhibition on cell
viability, UPR signaling, oxidative stress and NADPH oxidase
expression/activity. Our results indicate that proteasome inhibi-
tion, per se at non-lethal levels, suppresses ER stress-induced UPR
signaling and Nox4 expression, but intriguingly increases XBP1
mRNA splicing. In parallel, proteasome inhibition sensitizes
vascular smooth muscle cells to ER stress-induced death, through
mechanisms not clearly dependent on ROS.
Results
Proteasome inhibition at non-lethal levels potentiate
endoplasmic reticulum stress-induced cell death
Initial experiments were directed to establish concentrations of
proteasome inhibitor not associated with cell death within the time
frame of our experiments, since cell loss might be accompanied by
possible secondary redox and other signaling events. VSMC were
incubated in the absence of serum with a range of concentrations
of the proteasome inhibitor MG132 (0.1 to 10 mM for 24 h). Cell
loss detected by MTT assays started to appear at concentrations
equal to or above 3 mM, so that results shown in Fig. 1A reflect
data obtained with the 1 mM concentration, chosen for all
subsequent experiments. Importantly, such concentration was
shown to effectively inhibit proteolytic proteasome activity (Fig. 2).
Additional experiments (not shown) showed that the presence of
serum provided protection against VSMC death up to 10 mM
MG132 concentration. Viability experiments were also performed
in presence of the known ER stressor tunicamycin (Tn, 5 mg/mL).
Although MG132 at 1 mM concentration was unassociated with
significant loss in cell viability, co-incubation of VSMC with Tn
plus MG132 induced significant increase in cell loss compared to
Tn alone (Fig. 1A). To further assess the effects of MG132 in cell
death, western blot experiments were performed against procas-
pase-3 and caspase-3. Results shown in Fig. 1B indicate a clearly
increased cleavage of procaspase-3 with combined incubation of
Tn and MG132, in comparison with either compound alone.
These data indicate that apoptosis is one mechanism of cell death
whereby proteasome inhibition potentiates ER stress-induced
lethality.
Validation of MG132effects regarding proteasome
inhibition
To assess whether increase in proteasome activity is a normal
constituent of the UPR, we assessed 20S proteasome activity
(chymotrypsin-like) at several times after starting incubation with
Tn. As early as 2 (data not shown) and 4 h of incubation (Fig. 2A),
proteasome activity was significantly increased by ,30%. By 16 h
of incubation (Fig. 2B), proteasome activity returned toward
baseline levels. Importantly, incubation with MG132 (1 mM) alone
or in combination with Tn was capable of significantly inhibiting
chymotrypsin-like activity. Since both chymotrypsin-like activity
measurement and MG132 action can display some lack of
specificity vs. the proteasome, we further assessed the level of
total poly-ubiquitinated proteins (Fig. 3) after 2, 4 or 16 h of
incubation with Tn, MG132 (1 mM), or their combination.
Western analysis showed significant increase in polyubiquitinated
proteins, especially at higher molecular weights, at 2 and 4 h (and
less evident at 16 h) after MG132, in the absence or not of Tn.
The increased chymotrypsin-like activity at 2 and 4 h (Fig. 2A) was
not paralleled by detectable decrease in polyubiquitinated
proteins, probably because of their already low levels at baseline.
Together, these data validate the specificity of MG132 at the
1 mM concentration in our experimental conditions.
Proteasome inhibition down-regulates UPR signaling
The pattern of early, but not sustained proteasome activity
increase during ER stress shown above prompted us to investigate
whether the proteasome might be involved in UPR signaling.
Incubation of VSMC with the ER stressor Tn (5 mg/mL, 16 h) is
Figure 1. Proteasome inhibition sensitizes VSMC to death due
to ER stress. (A) Representative graph of VSMC cell viability by MTT
assay. VSMC were incubated with tunicamycin (Tn) (5 mg/mL) or/and
MG132 (1 mM) for 16 h, followed by MTT assays. (B) Similar to A, VSMC
were incubated with Tn (5 mg/mL) or/and MG132 (1 mM) for 16 hours.
Total cell homogenates were submitted to western analysis with anti-
caspase-3 antibody. Data are mean 6 SD of 3 independent
experiments.*P,0.05 vs. Control. #P,0.05 vs.Tn.
doi:10.1371/journal.pone.0014591.g001
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chaperones such as Grp78 and Grp94, as seen in Fig. 4A.
Incubation with MG132 alone promoted mild/moderate increases
in the expression of such proteins, while co-incubation of Tn and
MG132 significantly prevented their increase in comparison to Tn
alone. Under the conditions of our experiments, Tn incubation
promoted significant increase in protein expression of the ER
redox chaperone protein disulfide isomerase (PDI). While PDI
expression was not affected by incubation with MG132 alone
(1 mM, 16 h), its co-incubation with Tn completely prevented the
increase in PDI protein (Fig. 4B). Real-time PCR analysis of PDI
mRNA showed results in line with those depicted for protein
expression. VSMC incubation with Tn (5 mg/mL, 16 h) strongly
increased PDI mRNA. Again, while MG132 alone was without
effect, co-incubation of MG132 with Tn completely prevented the
increase in PDI mRNA (Fig. 4C).
Expression of Grp- or PDI-like chaperones represents a major
branch of proadaptive signaling during the UPR [2,3]. To assess
whether proteasome inhibition also affects proapoptotic UPR
signaling, we assessed the expression of CHOP/GADD transcrip-
tion factor in the nuclear fraction of VSMC incubated with Tn,
MG132 or their combination. Incubation with Tn (5 mg/mL,
16 h) showed the expected strong increase in CHOP expression,
consistent with the increase in cell loss verified in Fig. 1A
experiments. MG132 incubation (1 mM, 16 h) was without effect,
but co-incubation of MG132 (1 mM) and Tn significantly inhibited
the nuclear expression of CHOP/GADD 153 (Fig. 5A), indicating
that proteasome inhibition suppresses not only proadaptive but
also proapoptotic signaling and that potentiation of Tn-induced
cell death by proteasome inhibition does not appear to occur
through the canonical ER stress-dependent pathway.
Proteasome inhibition enhances XBP1 splicing
The transcription factor XBP1 has an unusual mode of
regulation in which its mRNA is spliced in the cytosolic face of
the ER by the endonuclease action of IRE1a, with removal of an
intronic sequence, generating the mRNA for the active spliced
transcription factor, while the unspliced form acts as a dominant-
negative UPR inhibitor [2,29]. The spliced form of XBP1 mRNA
generates a transcription factor that codes for proteins that
account for a number of functions that converge to cell survival
and ER homeostasis, DNA repair, cell differentiation [30] and
protection against oxidative stress [31]. In myeloma cells, MG132
Figure 2. Activity of 20S proteasome in VSMC at control
condition or after incubation with AngII (200 nM) or Tn (5 mg/
mL), in the absence or presence of MG132 (1 mM) during 4 (A)
or 16 (B) hours. Cell lysates were incubated with probe AMC (LLVY-
AMC) in the presence of SDS and fluorescence release followed over
15–30 min (excitation 355 nm, emission 460 nm). Data are mean 6 SD
of 4 or more independent experiments.*P,0.05 vs. Control. #P,0.05
vs. Tn.
doi:10.1371/journal.pone.0014591.g002
Figure 3. Total polyubiquitinated protein levels after Tn, MG132 or their combination, at 2, 4 or 16 h of incubation with VSMC.
Western analysis of VSMC lysates was performed in 8% polyacrilamide gels and probed with anti-ubiquitin antibody. Representative of at least 3
experiments per group.
doi:10.1371/journal.pone.0014591.g003
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Analysis of XBP1 mRNA splicing in our VSMC through RT-PCR
showed the expected robust increase in the spliced form with Tn
(5 mg/mL, 16 h). Surprisingly, however, MG132 alone and
particularly in combination with Tn also promoted a strong
increase in XBP1 splicing (Fig. 5B and C). Strong activation of
such UPR survival pathway further suggests that MG132-induced
increase in Tn-triggered apoptosis occurred through pathways
unrelated to canonical UPR proapoptotic signaling.
Phosphorylation of Akt and p38 MAPK after proteasome
inhibition
To further investigate the consequences of proteasome inhibi-
tion in downstream signaling pathways involved with survival and
stress, we assessed Akt/protein kinase B and p38 phosphorylation.
VSMC incubated with MG132 (1 mM) for time periods varying
from 2 - 18 h showed sustained increases in Akt phosphorylation
(Fig. 6A). For p38, MG132 incubation times of 0.5, 4 and 16 h
also showed persistent increase in phosphorylation, not detectably
time-dependent (not shown). In additional experiments (Fig. 6B),
VSMC were incubated for 16 h with AngII (200 nM, used as a
positive control) or Tn (5 mg/mL), showing no increase in p38
phosphorylation. Contrarily, incubation with MG132 (1 mM)
alone showed that p38 phosphorylation was significantly in-
creased, while MG132 co-incubation with AngII or Tn induced
no further detectable changes.
We next investigated the importance of Akt in cell death
induced by Tn, MG132 or their combination. For these studies
Figure 4. Down-regulation of UPR signaling by MG132. VSMC were incubated with Tn (5 mg/ml), MG132 (1 mM) or their combination for 16 h.
Total cell homogenates were submitted to western analysis with anti-KDEL (A) or anti-PDI antibodies (B). Graphs to the right are corresponding
densitometric measurements of blots shown in (A) and (B) for at least 3 independent experiments; (C) Analysis of PDI mRNA by real-time PCR. VSMC
were incubated with vehicle or Tn (5 mg/mL) in the absence or presence of MG132 (1 mM) for 16 h; n=3. Data are mean 6 SD. *P,0.05 vs. Control.
#P,0.05 vs.Tn.
doi:10.1371/journal.pone.0014591.g004
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mL) and/or MG132 (1 mM) for 16 h in the presence or absence of
an Akt inhibitor (A6730 Sigma-Aldrich). Results showed that Akt
inhibition increased cell death vs. control already at baseline
conditions, but was particularly lethal after Tn, MG132, or their
combination. Also, such increase in cell death was greater with the
co-incubation of Tn and MG132 in comparison with Tn alone.
This indicates that Akt significantly contributes to cell survival
during either ER stress or proteasome inhibition in an additive
way.
Proteasome inhibitor induces ROS production and
disrupts NADPH oxidase activity
Since ROS production and NADPH oxidase activity are
integral components of the UPR, we investigated effects of
proteasome inhibition on these variables. Experiments to assess
ROS production were performed at 4-h incubation periods, in
order to detect early changes that would be likely independent of
secondary signaling events, as well as apoptosis itself [5].
Generation of 2-hydroxyethidium and ethidium products of
DHE was assessed after 4-h incubation with Tn (5 mg/mL),
MG132 (1 mM) or their combination (Fig. 7A). Either Tn or
MG132 induced increase in ROS signals, while their combination
was not additive. Reports from other [6,7] and our [5] laboratories
showed previously that ER stress induces Nox4 mRNA expression
in VSMC and that such induction is able to modulate either
proadaptive or proapoptotic signaling [5–7]. We first assessed the
effects of proteasome inhibitors in membrane fraction NADPH
oxidase activity. VSMC were incubated for 4 h with Tn, MG132
or their combination and NADPH-driven ROS generation was
assessed in membrane fraction with DHE assay (Fig. 7B).
Incubation with MG132 alone produced non-significant changes.
However, MG132 co-incubation with Tn remarkably switched the
response to Tn from 83% increase to 58% decrease in NADPH
oxidase activity (Fig. 7B). These results indicate that proteasome
inhibition strongly disrupts ER stress-induced NADPH oxidase
up-regulation.
Proteasome inhibition abrogates Nox4 mRNA expression
after ER stress
NADPH oxidase activation in non-phagocytic cells is charac-
terized by increases in mRNA or protein expression of relevant
catalytic or regulatory subunits [32]. Thus, we quantitatively
assessed the effects of ER stress and proteasome inhibitor MG132
in mRNA levels of Nox4 and compared them to Nox1, another
isoform consistently expressed in VSMC [5,28,32] (Fig. 8). Since
AngII is a canonical stimulus for Nox1 and does not by itself
increase UPR markers in the conditions of our experiment [5],
results were also analyzed after VSMC incubation with this
peptide. Data are reported for 16-h incubations, since detectable
Figure 5. Effects of proteasome inhibition on nuclear CHOP/GADD153 expression and XBP1 mRNA splicing. (A) Representative
western analysis of CHOP/GADD153 protein expression in nuclear extracts of VSMC incubated with Tn (5 mg/ml) or/and MG132 (1 mM) for 16 h.
(B) Agarose gel depicting the amplified PCR products corresponding to spliced or unspliced forms of XBP1 mRNA, obtained from VSMC submitted to
the same conditions as in (A). (C) Graph depicting densitometric analysis of data from (B). Data are mean 6 SD of 3 independent experiments.
*P,0.05 vs. unspliced control. #P,0.05 vs. spliced control.
doi:10.1371/journal.pone.0014591.g005
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Nox4 after Tn [5]. Additional experiments performed at earlier
stages showed increased variability (not shown). MG132 (1 mM)
alone induced no evident changes in Nox4, as well as Nox1
mRNA levels. Incubations with AngII (200 nM) or Tn (5 mg/mL)
induced preferentially the expected increases in Nox1 or Nox4
mRNA levels, respectively. However, their co-incubation with
MG132 significantly altered this expression pattern. Nox1 average
increase with AngII was attenuated from 87 to 29% while,
remarkably, Nox4 mRNA increase with Tn was essentially
abolished after co-incubation with MG132 (Fig. 8B). We also
assessed mRNA expression of p22phox in the same conditions as
above, but detected no significant changes (data not shown).
ROS scavenging does not preserve cell viability in ER
stressed-VSMC after proteasome inhibition
To investigate whether ROS played a direct effect on cell
viability during proteasome inhibition in ER-stressed VSMC, we
co-incubated VSMC with Peg-CAT plus Peg-SOD in the same
conditions and then performed MTT assays (Fig. 9). These
experiments showed no significant changes in cell viability in the
presence of such ROS scavengers.
Discussion
Our data showed that proteasome inhibition, per se at non-
lethal levels, sensitizes VSMC to cell death during ER stress
Figure 6. Akt and p38 phosphorylation by MG132 in VSMC. (A) Representative immunoblotting depicting phosphorylated and total Akt
expression at baseline or after incubation with MG132 (1 mM) for 2, 6 or 16 h. Graph to the right depicts quantitative densitometric analysis of Akt
expression from 3 blots similar to (A). (B) Representative immunoblotting depicting phosphorylated and total p38MAPK expression at baseline or
after incubation with angiotensin II, tunicamycin, MG132 (1 mM, 16 h) or their combination; representative of n=3. (C) Graph summarizing the effect
of Akt inhibition on enhancement of VSMC death. VSMC were incubated with Tn (5 mg/mL) or/and MG132 (1 mM) for 16 h in the absence or presence
of Akt inhibitor (A6730 Sigma-Aldrich), followed by MTT assays. Data are mean 6 SD of 3 independent experiments.*P,0.05 vs. Control. #P,0.05
vs.Tn.
doi:10.1371/journal.pone.0014591.g006
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suppression of both proadaptive and proapoptotic markers of
classical UPR signaling, although, intriguingly, the splicing of
XBP1 was markedly enhanced and sustained. In parallel,
proteasome inhibition induced complete disruption of NADPH
oxidase activity and regulation and of Nox4 mRNA triggered by
ER stress. Although oxidative stress was increased, ROS
scavenging with PEG2SOD + PEG2CAT had no net effect on
VSMC death in our model. Despite the increase in ER stress-
induced cell death, proteasome inhibition also promoted survival/
stress signaling such as phosphorylation of p38MAPK and Akt, the
latter shown to partially offset VSMC death. Together, these data
indicate mechanisms of the stress response and redox signaling
Figure 7. Proteasome inhibition induces ROS production and
disrupts ER stress-induced NADPH oxidase up-regulation.
(A) ROS production in VSMC incubated for 4 h with Tn (5 mg/mL) or/
and MG132 (1 mM), assessed through HPLC analysis of DHE oxidation
products (50 mM, 30 min incubation), as described in Methods. Results
depict levels of 2-hydroxyethidium (EOH) or ethidium (E) products.
(B) NADPH oxidase activity measured in membrane-enriched homog-
enates from VSMC incubated for 4 h with Tn or MG132. Activity was
measured with DHE technique, analogous to (A), as described in
Methods. Data are mean 6 SD of 3 independent experiments.*P,0.05
vs. Control. #P,0.05 vs.Tn.
doi:10.1371/journal.pone.0014591.g007
Figure 8. Proteasome inhibition strongly inhibits ER stress-
induced Nox4 expression. (A) Real-time PCR analysis of Nox1 mRNA
levels. VSMC were incubated with AngII (200 nM) or Tn (5 mg/mL) in the
absence or presence of MG132 (1 mM) for 16 h; (B) Similar to (A), with
analysis of Nox4 mRNA levels. In both (A) and (B), data are expressed as
the ratio of Nox expression/total DNA expression in the same sample.
Data are mean 6 SD of 5 independent experiments.*P,0.05 vs. Control.
#P,0.05 vs. Tn.
doi:10.1371/journal.pone.0014591.g008
Figure 9. Effects of ROS scavenging in VSMC viability after ER
stress or/and proteasome inhibition. VSMC were incubated with
Tn (5 mg/mL) or/and MG132 (1 mM) for 16 h in the absence or presence
of PEG-Cat (200 U/ml) plus PEG-SOD (25 U/ml). Data are mean 6 SD of
3 independent experiments.*P,0.05 vs. Control. #P,0.05 vs.Tn.
doi:10.1371/journal.pone.0014591.g009
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which may be of relevance to understand the therapeutic potential
of such compounds in vascular diseases.
The mechanisms whereby proteasome inhibition sensitizes ER-
stressed VSMC to apoptosis may be multiple, but a likely major
factor was the suppression of homeostatic UPR signaling such as
failure to upregulate classical chaperone markers including Grp78,
Grp94, as well as PDI. Disruption of UPR signaling is known to
sensitize cells to death in response to ER stressors [1,2,8,9,11].
Such conversion from adaptive to apoptotic signaling, however,
likely occurs through distinct mechanisms than those associated
with sustained/intense ER stress. While the latter involves
canonical UPR pathways such as CHOP/GADD153, the former
likely involves UPR-independent pathways, as shown in our study
by the lack of activation of such transcription factor. In fact,
proteasome inhibitors induce a complex cell stress response,
including in some instances UPR signaling itself, which reflects
disruption of misfolded protein degradation [8,18]. In our VSMC,
however, this response was quite modest, possibly due to the
moderate concentrations of MG132. Proteasome inhibition may
also promote reversible arrest in protein synthesis [17], possibly
reminiscent of an integrated cell stress response [2]. Another effect
of proteasome inhibition may be autophagy [37]. This process,
however, was reportedly triggered via UPR-dependent pathways
[36], which were suppressed in our VSMC.
The UPR-independent pathways that culminate in executioner
caspase-3 activation and apoptosis in our VSMC were likely
complex, as in most other studies dealing with proteasome
inhibitor-mediated apoptosis. Evidence suggests that these trig-
gering pathways are upstream of mitochondrial dysfunction and
caspases, and seem to converge to persistent activation of
proapoptotic bcl-2 family proteins[18,33,34], inhibition of NF-
kB activation [18], or inhibition of FoxM1 transcription factor
[35]. In addition, evidence for a negative reciprocal regulatory
interaction between the 26S-proteasome and executioner caspases
was recently described, suggesting that proteasome inhibition may
directly unleash activity of executioner caspases [36]. It is precisely
this variety of proapoptotic mechanisms that makes proteasome
inhibition a valuable strategy for eluding homeostatic/adaptive
pathways responsible for tumor resistance [33] and possibly
neointima formation [18,19].
A frequent [18,38–40] though not universal [13,14] effect of
proteasome inhibition is oxidative stress, associated with ROS
generation and in some cases with disrupted mitochondrial
membrane potential [15,40]. Although ROS production was
increased in our VSMC, incubation with ROS scavengers SOD
and catalase did not significantly prevent sensitization to ER-
induced apoptosis by proteasome inhibition, suggesting that the
overall mechanism of cell death is not directly related to ROS
themselves, or that ROS are consequence rather than cause of the
cell death process. Since SOD and catalase were not targeted to
specific organelles, we cannot exclude that an early ROS-
dependent event in a specific subcellular compartment triggered
subsequent ROS-independent apoptotic events that were executed
in the cytosol. In addition, it is not inappropriate to propose that
these findings can also reflect complex effects of ROS in which
both proapoptotic and prosurvival signals are redox-transduced
and the overall balance remains neutral. Indeed, Nox4-dependent
ROS in the ER were shown to trigger autophagy signaling
during ER stress, while Nox4 silencing switched the response to
apoptosis [7].
The induction of survival signals such as XBP1 and particularly
Akt phosphorylation, concomitant to cell death sensitization by
proteasome inhibition is in line with the complex cell stress
response triggered by such compounds and significantly limited
VSMC loss. The role of Akt in cell survival during ER stress has
been described previously [41–43] in a way that this kinase may be
a key element in the transition from proadaptive to proapoptic
signaling. Since in our cells the UPR was largely suppressed by
proteasome inhibition, the additive prosurvival effect of Akt in face
of proteasome inhibition (Fig. 6C) is likely to involve a distinct,
UPR-independent, pathway. It is important to consider that in
proliferating cells, proteasome inhibition tends to induce apoptosis,
whereas in differentiated cells such as neurons these compounds
may reduce apoptosis [39]. This may be relevant to VSMC, which
show a high degree of phenotypic modulation during vascular
response to injury.
The mechanisms whereby proteasome inhibition suppressed the
UPR in our VSMC are unknown. In striking contrast with the
other UPR markers assessed in our cells, as well as with findings
reported for myeloma cells [11], XBP1 splicing was increased in
VSMC after proteasome inhibition, particularly in concomitance
with ER stress. XBP1 splicing is an important adaptive component
of the UPR, inducing genes coding for chaperones, ER
homeostatic proteins, DNA repair and particularly for antioxidant
enzymes [30,31]. In cardiomyocytes, proteasome inhibition
promotes the induction of CHOP and ATF6 transcription factors,
but not XBP1 or KDEL chaperones [14]. Therefore, it is possible
that the response of XBP1, as well as that of UPR signaling in
general, to proteasome inhibition is particularly cell-specific.
Importantly, the activation of XBP1 in a proapoptotic scenario
such as our model is by no means inconsistent with known
pathways of UPR regulation. First, although spliced XBP1 has
many protective targets, it can also induce the Hsp40 family
member p58
IPK, which may precipitate cell death by releasing
PERK-dependent inhibition of protein translation [44]. Second, in
a model of genetic deficiency of the anti-apoptotic protein BI-1
(Bax inhibitor-1), which regulates the UPR by inhibitory
association with IRE1a, there was marked and persistent XBP1
splicing despite increased sensitivity to ER stress-mediated
apoptosis [45,46]. This highlights the increasing focus on IRE1a
as a main regulator of ER stress-related apoptosis [46]. Another
proapoptotic regulatory signal converging to this pathway is
protein tyrosine phosphatase 1B (PTP-1B), which regulates the
UPR via IRE1a activation [47]. Since Nox4, known to be induced
by UPR [5–7], strongly inhibits PTP-1B [48,49], one can
speculate a model in which suppression of Nox4 by proteasome
inhibition allows PTP1-B to potentiate IRE1a and consequently
XBP1 activation, within a proapoptotic scenario.
The potential mechanisms of Nox4 repression after proteasome
inhibition can be multiple and our data may help understand the
intriguing and so far poorly understood regulation of this NADPH
oxidase isoform. One possible explanation for this effect is the
known transcriptional role of the proteasome, which has been
increasingly recognized [50,51]. In addition to transcription, the
mild UPR triggered by proteasome inhibition in VSMC may
induce translation repression [17]. Finally, the proteasome may
potentially regulate levels of relevant transcription factor proteins
[52]. Importantly, the regulation of Nox4 activity appears to
strongly correlate with its mRNA levels [53]. Therefore, the effects
of proteasome inhibition during the UPR may directly impact on
Nox4 activity and ROS production at the oxidase milieu, as in fact
reflected in the marked prevention, by MG132, of NADPH
oxidase activity upregulation due to Tn. In parallel with Nox4, our
results show that proteasome inhibition also impairs mRNA and
protein expression of PDI. This is relevant because we showed
previously that PDI associates, among other NADPH oxidase
subunits, with Nox4 [26,54]. Down-regulation of PDI prevents
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observations from our laboratory). Very little is known about
regulatory mechanisms of PDI transcription in eukaryotes, in part
because abundantly expressed PDI seems regulated at the level of
protein expression, translocation and perhaps post-translational
modifications [54].
In summary, our results indicate that proteasome inhibition
impairs VSMC viability during ER stress, while largely suppress-
ing proadaptive and proapoptotic UPR signals, although not
XBP1 splicing. The mechanism of such death sensitization likely
involves a complex cell stress response induced by proteasome
inhibitors, as suggested by the concomitant induction of survival
signals such as Akt phosphorylation. In addition, Nox4 as well as
PDI induction by ER stress were importantly inhibited by
proteasome inhibition. Overall, VSMC death sensitization due
to proteasome inhibition did not seem directly dependent on
ROS, despite increases in ROS production. ER stress plays a
significant role in the pathogenesis of atherosclerotic vascular
disease, as well as its complications and risk factors such as
hyperlipidemia and insulin resistance [1]. Moreover, such a role is
paralleled by interaction between the proteasome and inflamma-
tion via NFkB, cytokines and survival pathways [18]. Our results
may help understand the involvement of the proteasome in the
pathogenesis of vascular disease, as well as clarifying the potential
therapeutic role of proteasome inhibitors in atherosclerosis.
Materials and Methods
Materials
Antibodies were obtained as follows: PDI and KDEL from
Assay Designs/Stressgen (Ann Arbor, MI); CHOP/GADD153
from Thermo Scientific (Golden, CO); Akt, phospho-Akt, p38 and
phospho-p38 from Cell Signaling Technology (Danvers, MA);
ubiquitin from Zymed/Invitrogen (San Francisco, CA); b-actin
from Sigma-Aldrich (St. Louis, MO). Secondary antibodies
conjugated with horseradish peroxidase, 20S proteasome activity
kit and protease inhibitors were from EMB Biosciences (San
Diego, CA, USA). Dihydroethidium (DHE) was from Invitrogen
(Carlsbad, CA). All other reagents were from Sigma-Aldrich
(St. Louis, MO).
Cell culture and ER stress induction
Rabbit aortic smooth muscle cells (VSMC) were obtained from
a previously established selection-immortalized line, as reported
previously [26] and maintained in growth medium (F12+10% fetal
bovine serum + streptomycin 100 mM + penicillin 100 U/mL). In
specific experiments, VSMC were incubated with angiotensin II
(AngII) at a final 200 nM concentration in the absence of FBS. For
induction of ER stress, VSMC were incubated for the indicated
periods of time with Tunicamycin (Tn) at 5 mg/mL concentration,
established by previous experiments to uniformly promote
expression of UPR signaling markers in our VSMC [5]. Tn is a
classical inducer of ER stress by virtue of its inhibitory effect on
N-glycosylation of nascent proteins destined to membranes or
extracellular secretion [2]. For proteasome inhibition, VSMC
were incubated with MG132 at 1 mM concentration for the
indicated periods of time. This concentration was established after
preliminary experiments (see Results), in which a wide range of
concentrations was tested, and is in line with concentrations used
in other studies from the literature [10,14].
MTT assays for cell viability
VSMC (2610
4 cells) were seeded and cultured for 24 h in a 96-
well plate, followed by further incubation for 24 h in presence or
absence of Tn or/and proteasome inhibitor MG132 at the
indicated concentrations, while during the last 4 h MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; 600 mM)
was added. VSMC were then washed with PBS (pH 7.4), followed
by DMSO, which solubilizes formazan crystals. Absorbance was
measured at 570 nm.
Measurement of ROS levels in VSMC by HPLC analysis of
DHE oxidation products
Cells grown in 6-well dishes (well area of 9.6 cm
2), at 90%
confluence, were incubated or not with Tn (5 mg/mL) or MG132
(1 mM) for 16 h. ROS generation was assessed through HPLC
analysis of DHE oxidation products, as described in detail
previously [27]. Briefly, cells kept in serum were washed twice
with PBS and incubated in the dark with PBS/DTPA (0.5 ml) and
DHE at final 50 mM concentration for 30 min in the absence of
serum. Cells were then washed 2x in cold PBS, harvested in
acetonitrile (0.5 ml/well), sonicated (10 s, 1 cycle at 8 W), and
centrifuged (12,000 g for 10 min at 4uC). Supernatants were dried
under vacuum (Speed Vac Plus model SC-110A, Thermo Savant)
and pellets maintained at 220uC in the dark until analysis.
Samples were then resuspended in 120 ml PBS/DTPA and
injected (100 ml) into an HPLC system equipped with a C18
column, Photodyode Array Detector (Waters 2996; for DHE) and
fluorescence detectors. This allowed simultaneous detection of
DHE and its derived oxidation products 2-hydroxyethidium
(EOH, which detects preferentially superoxide) and ethidium
(which detects less specific oxidants such as peroxides, as well as
heme and peroxide activity), using DHE as an internal control
during organic extraction of each sample [23]. Thus, DHE-
derived products were expressed as ratios of EOH or ethidium
generated per DHE consumed (initial minus remaining DHE
concentration) [27].
NADPH oxidase activity assay
Membrane fraction NADPH oxidase assays were performed as
described previously [5,26,27]. Briefly, VSMC were disrupted by
sonication in buffer containing Tris 50 mM, pH 7.4, EDTA
0.1 mM, EGTA 0.1 mM, and protease inhibitors (aprotinin
10 mg/mL, leupeptin 10 mg/mL and PMSF 1 mM) and centrifuged
(18,000 g, 15 min). After supernatant centrifugation (100,000 g, 1 h),
the obtained pellet (VSMC membrane fraction) was resuspended in
the same buffer. To assess NADPH-triggered superoxide production,
membrane homogenates (15 mg protein) were incubated with 10 mM
DHE in phosphate buffer (50 mM, pH 7.4) with DTPA 0.1 mM in
t h ep r e s e n c eo fN A D P H( 5 0 mM) and DNA (1.25 mg/mL) for
30 min at 37uC in the dark. Fluorescence was followed (excitation/
emission wavelengths for dihydroethidium: 490/590 nm) in a
microplate spectrofluorometer (SpectraMax M5, Molecular Devices),
as validated previously [27,28].
20S proteasome proteolytic activity assay
20S proteasome activity (chymotrypsin-like) was measured with
a Proteasome Assay Kit (EMD Biosciences) in VSMC homoge-
nates stimulated or not with Angiotensin II (200 nM – used as a
canonical Nox1 NADPH oxidase stimulus), Tn (5 mg/mL),
MG132 (1 mM) or Tn+MG132 combinations for 16 h. This assay
monitors the release of free AMC from the fluorogenic peptide
Suc-Leu-Leu-Val-Tyr-AMC. The rate of AMC release was
measured through the increase in fluorescence over time
(excitation max.: 380 nm; emission max.: 460 nm). VSMC
homogenates were obtained by cell lysis in RIPA buffer as
described above.
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Quantitative PCR was performed as described previously [28].
RNA was isolated with RNA SpinMini RNA isolation kit (GE
Healthcare) and was converted to cDNA by incubation of 3 mg
mRNA, 25 ng/L OligodT, 500 mM (each) dNTP, 5 mM dithio-
threitol and SuperScript II (Invitrogen) at 42uC for 50 min.
Quantitative PCR was performed with 150 ng of cDNA and Sybr
Mastermix (Invitrogen) and was analyzed with Rotor-Gene 6000
Software (Corbett Research). Forward primers designed according
to rabbit sequences were: Nox1 –CATCATGGAAGGAAGGA-
GA; Nox4 – CCACAGACTTGGCTTTGGAT; PDI – CGGCC-
CAGGAACTTCTTAAAGCCG; p22phox – GTACTTCATG-
GCGTAGGTGCCGAAGTAC.
Western blot
VSMC homogenates were obtained by cell lysis in RIPA buffer,
(Tris 20 mM, pH 8, NaCl 100 mM and glycerol 10%), with
protease inhibitors (aprotinin 10 mg/mL, leupeptin 10 mg/mL,
PMSF 1 mM) and Triton-100 10%. After 20 min on ice, samples
were centrifuged (10,000 g, 10 min) and supernatants analyzed in
SDS–PAGEasdescribed[5,27,28].Geldensitywas12%,exceptfor
polyubiquitin gels (Fig.4), which was 8%. After protein transfer to
nitrocellulose membrane, membranes were blocked with non-fat
milk (5%, 2 h), blotted with primary antibodies overnight, and with
secondary antibodies conjugated with horseradish peroxidase and
luminescence was obtained by membrane incubation with chemi-
luminescence solution (luminol 2.5 mM, p-cumarinic acid 0.4 mM,
H2O2 5.4 mM, Tris 0.1 mM, pH 8.5). Densitometric analysis was
performed with ImageQuant
TM 2005 software (GE Healthcare).
Nuclear extracts used for the analysis of CHOP protein levels
were obtained as reported [5]. Briefly, VSMC (,1610
6 cells)
grown in 10-mm dishes and exposed to experimental conditions
were washed twice with cold PBS, scraped in 1 ml PBS-EDTA
and transferred to 1.5 ml tubes. Cells were centrifuged at
2,500 rpm/5 min, pellets resuspended in 200 ml harvest buffer
and incubated on ice for 5 min. Samples were centrifuged at
1000 rpm/10 min and nuclei pellet were washed twice with
500 ml buffer A (Hepes pH 7.0, 10 mM KCl, 0.1 mM EDTA,
0.1 mM EGTA) containing leupeptin (2 mg/ml), pepstatin (2 mg/
ml), phenylmethylsulfonyl fluoride (44 mg/ml). Finally, pellets were
resuspended in buffer C (10 mM HEPES, pH 7.9, 500 mM NaCl,
0.1 mM EDTA, 0.1 mM EGTA, 0.1% IGEPAL, containing
leupeptin (2 mg/ml), pepstatin (2 mg/ml), PMSF (44 mg/ml).
Samples were vigorously vortexed for 15 min at 4uC and after
final centrifugation at 14000 rpm/10 min, supernatant containing
20 mg nuclear extracts was used for western blotting.
XBP1 mRNA splicing
XBP1 mRNA splicing was detected according to published
protocols [29]. Total RNA was extracted from 3.5610
6 VSMC
incubated with or without Tn (5 mg/mL) and/or MG132 (1 mM)
by using the Illustra mini RNA isolation kit (GE Healthcare). RT-
PCR for samples was performed with Platinum Taq Polymerase
from Invitrogen (Carlsbad, CA). PCR for XBP1 was performed
with 3 mg cDNA and the primer sequences were AGA-
GAAAACTCATGGCCTTGTCATTG and GAAGAGTCAGC-
GCCGTCAGAA. PCR products were separated on a 3% agarose
gel, which yielded a 238 bp product for unspliced and a 212 bp
fragment for spliced XBP1 mRNA. PCR for GAPDH was
performed under the same conditions with primer sequences
TCACCATCTTCCAGGAGCG and CACAATGCCGAAGT-
GGTCGT, except that PCR products were separated on conven-
tional agarose gels.
Statistical analysis
Values are expressed as mean 6 standard deviation. Statistical
comparisons were performed through one-way analysis of variance
(ANOVA), followed by Student–Newman Keuls test, at a 0.05
significant level (using The Primer of Biostatistics program, by
Stanton A. Glantz, version 3.01, McGraw-Hill, 1992).
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